| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| T J Littlejohns, K Kos, W E Henley, E Kuźma, D J Llewelly. Vitamin D and Dementia. The journal of prevention of Alzheimer's disease. vol 3. issue 1. 2019-11-20. PMID:29214280. |
studies have found that vitamin d is implicated in procognitive and neuroprotective functions, including the reduction of alzheimer's disease hallmarks such as amyloid beta and phosphorylated tau. |
2019-11-20 |
2023-08-13 |
human |
| Jonathan Orf, Scot Walke. BACE Inhibitors and Tau Protein Targeting Drugs in Prevention of Alzheimer's Disease. Hospital pharmacy. vol 52. issue 11. 2019-11-20. PMID:29276252. |
bace inhibitors and tau protein targeting drugs in prevention of alzheimer's disease. |
2019-11-20 |
2023-08-13 |
Not clear |
| Henrietta Wellington, Ross W Paterson, Aida Suárez-González, Teresa Poole, Chris Frost, Ulrika Sjöbom, Catherine F Slattery, Nadia K Magdalinou, Manja Lehmann, Eric Portelius, Nick C Fox, Kaj Blennow, Henrik Zetterberg, Jonathan M Schot. CSF neurogranin or tau distinguish typical and atypical Alzheimer disease. Annals of clinical and translational neurology. vol 5. issue 2. 2019-11-20. PMID:29468177. |
csf neurogranin or tau distinguish typical and atypical alzheimer disease. |
2019-11-20 |
2023-08-13 |
Not clear |
| Meng-Hui Dai, Hui Zheng, Ling-Dan Zeng, Yan Zhan. The genes associated with early-onset Alzheimer's disease. Oncotarget. vol 9. issue 19. 2019-11-20. PMID:29599933. |
alzheimer's disease (ad) is a progressive neurodegenerative disorder that accounts for the most cases of dementia, which is characterized by the deposition of dense plaques of amyloid beta (aβ) plaques and neurofibrillary tangles consisting of hyperphosphorylated tau. |
2019-11-20 |
2023-08-13 |
Not clear |
| PET Tau and Amyloid-β Burden in Mild Alzheimer's Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid Biomarkers. Journal of Alzheimer's disease : JAD. vol 63. issue 1. 2019-11-20. PMID:29660946. |
pet tau and amyloid-β burden in mild alzheimer's disease: divergent relationship with age, cognition, and cerebrospinal fluid biomarkers. |
2019-11-20 |
2023-08-13 |
Not clear |
| Ricardo B Maccioni, José Pablo Tapia, Leonardo Guzman-Martine. Pathway to Tau Modifications and the Origins of Alzheimer's Disease. Archives of medical research. vol 49. issue 2. 2019-11-20. PMID:29861329. |
pathway to tau modifications and the origins of alzheimer's disease. |
2019-11-20 |
2023-08-13 |
Not clear |
| S Gauthier, H Zhang, K P Ng, T A Pascoal, P Rosa-Net. Impact of the biological definition of Alzheimer's disease using amyloid, tau and neurodegeneration (ATN): what about the role of vascular changes, inflammation, Lewy body pathology? Translational neurodegeneration. vol 7. 2019-11-20. PMID:29876101. |
impact of the biological definition of alzheimer's disease using amyloid, tau and neurodegeneration (atn): what about the role of vascular changes, inflammation, lewy body pathology? |
2019-11-20 |
2023-08-13 |
Not clear |
| Victor L Villemagne, Vincent Doré, Samantha C Burnham, Colin L Masters, Christopher C Row. Author Correction: Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions. Nature reviews. Neurology. vol 14. issue 7. 2019-11-20. PMID:29880829. |
author correction: imaging tau and amyloid-β proteinopathies in alzheimer disease and other conditions. |
2019-11-20 |
2023-08-13 |
Not clear |
| Cara L Croft, Wendy Nobl. Preparation of organotypic brain slice cultures for the study of Alzheimer's disease. F1000Research. vol 7. 2019-11-20. PMID:29904599. |
alzheimer's disease, the most common cause of dementia, is a progressive neurodegenerative disorder characterised by amyloid-beta deposits in extracellular plaques, intracellular neurofibrillary tangles of aggregated tau, synaptic dysfunction and neuronal death. |
2019-11-20 |
2023-08-13 |
human |
| Cara L Croft, Wendy Nobl. Preparation of organotypic brain slice cultures for the study of Alzheimer's disease. F1000Research. vol 7. 2019-11-20. PMID:29904599. |
transgenic rodent models to study alzheimer's mimic features of human disease such as age-dependent accumulation of abnormal beta-amyloid and tau, synaptic dysfunction, cognitive deficits and neurodegeneration. |
2019-11-20 |
2023-08-13 |
human |
| Natalia Ermann, Piotr Lewczuk, Matthias Schmitz, Peter Lange, Tobias Knipper, Stefan Goebel, Johannes Kornhuber, Inga Zerr, Franc Lloren. CSF nonphosphorylated Tau as a biomarker for the discrimination of AD from CJD. Annals of clinical and translational neurology. vol 5. issue 7. 2019-11-20. PMID:30009207. |
creutzfeldt-jakob disease and alzheimer's disease are characterized by the presence of elevated total-tau cerebrospinal fluid concentrations while the presence of hyperphosphorylated tau forms in the cerebrospinal fluid is rather a hallmark of alzheimer's disease. |
2019-11-20 |
2023-08-13 |
Not clear |
| Hua Zhang, Kok Pin Ng, Joseph Therriault, Min Su Kang, Tharick A Pascoal, Pedro Rosa-Neto, Serge Gauthie. Cerebrospinal fluid phosphorylated tau, visinin-like protein-1, and chitinase-3-like protein 1 in mild cognitive impairment and Alzheimer's disease. Translational neurodegeneration. vol 7. 2019-11-20. PMID:30311914. |
cerebrospinal fluid phosphorylated tau, visinin-like protein-1, and chitinase-3-like protein 1 in mild cognitive impairment and alzheimer's disease. |
2019-11-20 |
2023-08-13 |
Not clear |
| Hua Zhang, Kok Pin Ng, Joseph Therriault, Min Su Kang, Tharick A Pascoal, Pedro Rosa-Neto, Serge Gauthie. Cerebrospinal fluid phosphorylated tau, visinin-like protein-1, and chitinase-3-like protein 1 in mild cognitive impairment and Alzheimer's disease. Translational neurodegeneration. vol 7. 2019-11-20. PMID:30311914. |
phosphorylated tau (p-tau) reflects the neuropathology of alzheimer's disease (ad) and is useful as diagnostic markers for ad. |
2019-11-20 |
2023-08-13 |
Not clear |
| Akihiko Takashim. Mechanism of neurodegeneration through tau and therapy for Alzheimer's disease. Journal of sport and health science. vol 5. issue 4. 2019-11-20. PMID:30356578. |
mechanism of neurodegeneration through tau and therapy for alzheimer's disease. |
2019-11-20 |
2023-08-13 |
Not clear |
| Ivan A Kuznetsov, Andrey Kuznetso. A numerical study of sensitivity coefficients for a model of amyloid precursor protein and tau protein transport and agglomeration in neurons at the onset of Alzheimer's disease. Journal of biomechanical engineering. 2019-11-20. PMID:30383187. |
a numerical study of sensitivity coefficients for a model of amyloid precursor protein and tau protein transport and agglomeration in neurons at the onset of alzheimer's disease. |
2019-11-20 |
2023-08-13 |
Not clear |
| Gwendoline Bourré, François-Xavier Cantrelle, Amina Kamah, Béatrice Chambraud, Isabelle Landrieu, Caroline Smet-Nocc. Direct Crosstalk Between Frontiers in endocrinology. vol 9. 2019-11-20. PMID:30386294. |
direct crosstalk between the formation of intraneuronal fibrillar inclusions of tau protein is associated with several neurodegenerative diseases referred to as tauopathies including alzheimer's disease (ad). |
2019-11-20 |
2023-08-13 |
Not clear |
| Einar M Sigurdsso. Tau Immunotherapies for Alzheimer's Disease and Related Tauopathies: Progress and Potential Pitfalls. Journal of Alzheimer's disease : JAD. vol 66. issue 2. 2019-11-20. PMID:30400102. |
tau immunotherapies for alzheimer's disease and related tauopathies: progress and potential pitfalls. |
2019-11-20 |
2023-08-13 |
Not clear |
| Cuicui Yang, Xuelian Li, Li Zhang, Yali Li, Lin Li, Lan Zhan. Cornel iridoid glycoside induces autophagy to protect against tau oligomer neurotoxicity induced by the activation of glycogen synthase kinase-3β. Journal of natural medicines. vol 73. issue 4. 2019-11-19. PMID:31190266. |
tau oligomers are the etiologic molecules of alzheimer's disease, and correlate strongly with neuronal loss and exhibit neurotoxicity. |
2019-11-19 |
2023-08-13 |
rat |
| Anuradha Venkatramani, Dulal Pand. Regulation of neuronal microtubule dynamics by tau: Implications for tauopathies. International journal of biological macromolecules. vol 133. 2019-11-14. PMID:31004638. |
abnormal functioning of tau is implicated in several neuronal disorders such as alzheimer's disease (ad) and parkinson's disease (pd), wherein tau forms insoluble aggregates and causes neurotoxicity. |
2019-11-14 |
2023-08-13 |
Not clear |
| Heiko Braak, Kelly Del Tredic. Spreading of Tau Pathology in Sporadic Alzheimer's Disease Along Cortico-cortical Top-Down Connections. Cerebral cortex (New York, N.Y. : 1991). vol 28. issue 9. 2019-11-13. PMID:29982389. |
spreading of tau pathology in sporadic alzheimer's disease along cortico-cortical top-down connections. |
2019-11-13 |
2023-08-13 |
Not clear |